Literature DB >> 21527130

Agreement on a pandemic influenza preparedness framework for the sharing of viruses and benefit sharing.

.   

Abstract

On 16 April 2011, a working group of World Health Organization (WHO) member states agreed on a pandemic influenza preparedness framework. It regulates the sharing of viruses within the WHO Laboratory Global Influenza Surveillance Network (GISN) and the access to vaccines, antiviral drugs, diagnostic kits, and other benefits, in particular with regard to lower-income countries. It foresees mandatory regular contributions from industry partners. The four-year negotiations by 193 WHO member states began in November 2007, at a time when concerns about the fair distribution of benefits impaired the timely global sharing of influenza sequences. The agreed framework will be presented to the World Health Assembly in May 2011 for its consideration and approval. The agreement will strengthen global preparedness for potential future influenza pandemics. More detailed background information and a comment on the implications of this achievement has been published by the European Centre for Disease Prevention and Control.

Mesh:

Substances:

Year:  2011        PMID: 21527130

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  3 in total

1.  Communication about vaccinations in Italian websites: a quantitative analysis.

Authors:  Silvio Tafuri; Maria S Gallone; Maria F Gallone; Ivan Zorico; Valeria Aiello; Cinzia Germinario
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

2.  Long-term respiratory follow-up of H1N1 infection.

Authors:  Paul Zarogoulidis; George Kouliatsis; Nikolaos Papanas; Dionysis Spyratos; Theodoros C Constantinidis; Ioannis Kouroumichakis; Paschalis Steiropoulos; Maria Mabroudi; Dimitris Matthaios; Theodora Kerenidi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis; Efstratios Maltezos
Journal:  Virol J       Date:  2011-06-25       Impact factor: 4.099

Review 3.  Disease X: accelerating the development of medical countermeasures for the next pandemic.

Authors:  Shmona Simpson; Michael C Kaufmann; Vitaly Glozman; Ajoy Chakrabarti
Journal:  Lancet Infect Dis       Date:  2020-03-17       Impact factor: 25.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.